

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of muscle hypertrophy (GO:0014741) | 9.69781205 |
| 2 | skeletal muscle tissue regeneration (GO:0043403) | 9.05616711 |
| 3 | locomotory exploration behavior (GO:0035641) | 8.78707954 |
| 4 | actin-myosin filament sliding (GO:0033275) | 8.68402175 |
| 5 | muscle filament sliding (GO:0030049) | 8.68402175 |
| 6 | regulation of transmission of nerve impulse (GO:0051969) | 8.50441861 |
| 7 | negative regulation of skeletal muscle tissue development (GO:0048642) | 8.09546655 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 7.77239265 |
| 9 | response to muscle activity (GO:0014850) | 7.53553444 |
| 10 | actin-mediated cell contraction (GO:0070252) | 7.08552351 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 7.07173385 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 6.13340409 |
| 13 | cellular response to dexamethasone stimulus (GO:0071549) | 6.02106132 |
| 14 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 5.85038262 |
| 15 | striated muscle adaptation (GO:0014888) | 5.67281963 |
| 16 | response to dexamethasone (GO:0071548) | 5.57129621 |
| 17 | response to activity (GO:0014823) | 5.49140934 |
| 18 | positive regulation of neurological system process (GO:0031646) | 5.48367958 |
| 19 | response to inactivity (GO:0014854) | 5.26437350 |
| 20 | actin filament-based movement (GO:0030048) | 5.16681734 |
| 21 | auditory behavior (GO:0031223) | 5.05571131 |
| 22 | exploration behavior (GO:0035640) | 4.98099448 |
| 23 | regulation of muscle hypertrophy (GO:0014743) | 4.97292728 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.93610392 |
| 25 | regulation of synapse maturation (GO:0090128) | 4.59899838 |
| 26 | regulation of DNA methylation (GO:0044030) | 4.59260868 |
| 27 | mechanosensory behavior (GO:0007638) | 4.57616622 |
| 28 | muscle adaptation (GO:0043500) | 4.56126513 |
| 29 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.46964923 |
| 30 | presynaptic membrane assembly (GO:0097105) | 4.39578920 |
| 31 | motor neuron axon guidance (GO:0008045) | 4.13212756 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 4.07768286 |
| 33 | myotube cell development (GO:0014904) | 4.07020274 |
| 34 | muscle organ development (GO:0007517) | 4.03605582 |
| 35 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.03129914 |
| 36 | muscle structure development (GO:0061061) | 4.02624054 |
| 37 | protein K6-linked ubiquitination (GO:0085020) | 4.01236771 |
| 38 | negative regulation of axon extension (GO:0030517) | 3.95803836 |
| 39 | skeletal muscle contraction (GO:0003009) | 3.93224082 |
| 40 | response to electrical stimulus (GO:0051602) | 3.80332790 |
| 41 | dosage compensation (GO:0007549) | 3.78827938 |
| 42 | negative regulation of developmental growth (GO:0048640) | 3.75652651 |
| 43 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.66387073 |
| 44 | protein trimerization (GO:0070206) | 3.65109794 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.57230764 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 3.53411073 |
| 47 | inositol metabolic process (GO:0006020) | 3.50746697 |
| 48 | skeletal muscle fiber development (GO:0048741) | 3.48996022 |
| 49 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.48479408 |
| 50 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.48479408 |
| 51 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.48479408 |
| 52 | tissue regeneration (GO:0042246) | 3.41442418 |
| 53 | lysine catabolic process (GO:0006554) | 3.40105180 |
| 54 | lysine metabolic process (GO:0006553) | 3.40105180 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31766256 |
| 56 | response to testosterone (GO:0033574) | 3.30992509 |
| 57 | forebrain cell migration (GO:0021885) | 3.26457135 |
| 58 | regulation of centriole replication (GO:0046599) | 3.21826909 |
| 59 | telencephalon cell migration (GO:0022029) | 3.17875824 |
| 60 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.16650756 |
| 61 | protein localization to synapse (GO:0035418) | 3.16129367 |
| 62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12391995 |
| 63 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.09251102 |
| 64 | muscle system process (GO:0003012) | 3.07909194 |
| 65 | negative regulation of organelle assembly (GO:1902116) | 3.06919752 |
| 66 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.02090022 |
| 67 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.00897811 |
| 68 | heparin biosynthetic process (GO:0030210) | 3.00033845 |
| 69 | heparin metabolic process (GO:0030202) | 3.00033845 |
| 70 | cranial nerve structural organization (GO:0021604) | 3.00018788 |
| 71 | muscle contraction (GO:0006936) | 2.96424949 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.94832081 |
| 73 | negative regulation of striated muscle tissue development (GO:0045843) | 2.94799407 |
| 74 | vocalization behavior (GO:0071625) | 2.94288210 |
| 75 | placenta development (GO:0001890) | 2.91698441 |
| 76 | response to auditory stimulus (GO:0010996) | 2.91011806 |
| 77 | positive regulation of synapse maturation (GO:0090129) | 2.87499592 |
| 78 | negative regulation of muscle tissue development (GO:1901862) | 2.86714251 |
| 79 | cellular response to glucocorticoid stimulus (GO:0071385) | 2.83602663 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.83416432 |
| 81 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.82627377 |
| 82 | righting reflex (GO:0060013) | 2.80477437 |
| 83 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.79360759 |
| 84 | cellular response to ketone (GO:1901655) | 2.78802865 |
| 85 | I-kappaB phosphorylation (GO:0007252) | 2.78315670 |
| 86 | negative regulation of muscle organ development (GO:0048635) | 2.76759532 |
| 87 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.72695622 |
| 88 | protein polyglutamylation (GO:0018095) | 2.72458082 |
| 89 | cellular response to corticosteroid stimulus (GO:0071384) | 2.66681282 |
| 90 | regulation of histone H3-K9 methylation (GO:0051570) | 2.62868908 |
| 91 | protein neddylation (GO:0045116) | 2.62742574 |
| 92 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.62600585 |
| 93 | striated muscle contraction (GO:0006941) | 2.61511045 |
| 94 | negative regulation of histone acetylation (GO:0035067) | 2.58243453 |
| 95 | response to gravity (GO:0009629) | 13.0156914 |
| 96 | skeletal muscle adaptation (GO:0043501) | 11.8692438 |
| 97 | striated muscle atrophy (GO:0014891) | 11.4983146 |
| 98 | regulation of neuron projection regeneration (GO:0070570) | 10.6113996 |
| 99 | regulation of axon regeneration (GO:0048679) | 10.6113996 |
| 100 | muscle atrophy (GO:0014889) | 10.2987636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 6.34857149 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.43917838 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.42194838 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.75971513 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.68429395 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40784394 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36350972 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 3.29089386 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 3.22795465 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.21116970 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.89159961 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.84423359 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58243512 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52823678 |
| 15 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.44469551 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.23233406 |
| 17 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.17275613 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.12521156 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.07883589 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97624066 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.94540998 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.86787028 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.85098544 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.84285490 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83658402 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83276979 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78699060 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77249339 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76258029 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72018828 |
| 31 | RXR_22108803_ChIP-Seq_LS180_Human | 1.61683273 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60684260 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.59166362 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56332028 |
| 35 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.55826741 |
| 36 | KDM2B_26808549_Chip-Seq_REH_Human | 1.54660943 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.54273986 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53411572 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.49478454 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48825349 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48517139 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46698083 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46214841 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41660645 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41492490 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41089434 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39870427 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39076309 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38333249 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37425585 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37274432 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37120840 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37020131 |
| 54 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.36229113 |
| 55 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.32087887 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31503299 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30252263 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29065966 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28300164 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26122948 |
| 61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25034048 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25034048 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24353035 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23774648 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18838504 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18076227 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18076227 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16956684 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15891767 |
| 70 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14353915 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14032983 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14032983 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12909625 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11168914 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09503516 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09503516 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07846998 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07489814 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06087516 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05760114 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04024402 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03894333 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03398388 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02291208 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02014077 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01105791 |
| 87 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00817747 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.00092368 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00041712 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99160245 |
| 91 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98886884 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97281625 |
| 93 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97215600 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97208670 |
| 95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96934986 |
| 96 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.96675124 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95927016 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93798325 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93631085 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93320463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002736_abnormal_nociception_after | 5.64154448 |
| 2 | MP0000747_muscle_weakness | 5.06783357 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 5.01048267 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 4.98260092 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.97120618 |
| 6 | MP0000749_muscle_degeneration | 3.88232599 |
| 7 | MP0002089_abnormal_postnatal_growth/wei | 3.82348697 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.41050799 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.22870205 |
| 10 | MP0004270_analgesia | 3.12705902 |
| 11 | MP0000759_abnormal_skeletal_muscle | 2.99353847 |
| 12 | MP0002269_muscular_atrophy | 2.96941710 |
| 13 | MP0000751_myopathy | 2.87318499 |
| 14 | MP0002108_abnormal_muscle_morphology | 2.49490733 |
| 15 | MP0003959_abnormal_lean_body | 2.44345716 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.35802222 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.32653112 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.27986598 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.23169848 |
| 20 | MP0000631_abnormal_neuroendocrine_gland | 2.18195483 |
| 21 | MP0005369_muscle_phenotype | 1.95109479 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.92590972 |
| 23 | MP0004885_abnormal_endolymph | 1.90050129 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 1.89968870 |
| 25 | MP0003880_abnormal_central_pattern | 1.85176379 |
| 26 | MP0000733_abnormal_muscle_development | 1.63140386 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.46052991 |
| 28 | MP0005083_abnormal_biliary_tract | 1.45455966 |
| 29 | MP0002272_abnormal_nervous_system | 1.41628585 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.36480407 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.34570799 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.28541081 |
| 33 | MP0000427_abnormal_hair_cycle | 1.25597195 |
| 34 | MP0001486_abnormal_startle_reflex | 1.25106320 |
| 35 | MP0003115_abnormal_respiratory_system | 1.22185086 |
| 36 | MP0000566_synostosis | 1.21700759 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.21553737 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.19983379 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.19501490 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.19256732 |
| 41 | MP0010307_abnormal_tumor_latency | 1.19039191 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.17440623 |
| 43 | MP0004484_altered_response_of | 1.08396778 |
| 44 | MP0003045_fibrosis | 1.06493207 |
| 45 | MP0005187_abnormal_penis_morphology | 1.05156935 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.04941232 |
| 47 | MP0003632_abnormal_nervous_system | 1.02161857 |
| 48 | MP0008057_abnormal_DNA_replication | 1.01336413 |
| 49 | MP0003646_muscle_fatigue | 1.00889430 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.00758081 |
| 51 | MP0005408_hypopigmentation | 0.94000677 |
| 52 | MP0002733_abnormal_thermal_nociception | 0.92865269 |
| 53 | MP0004142_abnormal_muscle_tone | 0.92493154 |
| 54 | MP0005171_absent_coat_pigmentation | 0.91243482 |
| 55 | MP0004084_abnormal_cardiac_muscle | 0.89924351 |
| 56 | MP0001970_abnormal_pain_threshold | 0.88507311 |
| 57 | MP0000467_abnormal_esophagus_morphology | 0.88284834 |
| 58 | MP0002095_abnormal_skin_pigmentation | 0.85580904 |
| 59 | MP0009250_abnormal_appendicular_skeleto | 0.81246335 |
| 60 | MP0003937_abnormal_limbs/digits/tail_de | 0.79462144 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 0.79146065 |
| 62 | MP0005386_behavior/neurological_phenoty | 0.78216576 |
| 63 | MP0004924_abnormal_behavior | 0.78216576 |
| 64 | MP0002115_abnormal_skeleton_extremities | 0.77405152 |
| 65 | MP0002332_abnormal_exercise_endurance | 0.76180246 |
| 66 | MP0002184_abnormal_innervation | 0.75964430 |
| 67 | MP0003786_premature_aging | 0.74414014 |
| 68 | MP0003950_abnormal_plasma_membrane | 0.73943288 |
| 69 | MP0000778_abnormal_nervous_system | 0.73691011 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 0.71268651 |
| 71 | MP0001440_abnormal_grooming_behavior | 0.70817332 |
| 72 | MP0009745_abnormal_behavioral_response | 0.70123169 |
| 73 | MP0004133_heterotaxia | 0.69401051 |
| 74 | MP0002109_abnormal_limb_morphology | 0.67820638 |
| 75 | MP0002557_abnormal_social/conspecific_i | 0.67718726 |
| 76 | MP0002114_abnormal_axial_skeleton | 0.63696275 |
| 77 | MP0001943_abnormal_respiration | 0.62031408 |
| 78 | MP0003385_abnormal_body_wall | 0.58065309 |
| 79 | MP0002063_abnormal_learning/memory/cond | 0.57824857 |
| 80 | MP0003631_nervous_system_phenotype | 0.57297785 |
| 81 | MP0000920_abnormal_myelination | 0.56958171 |
| 82 | MP0000647_abnormal_sebaceous_gland | 0.56293457 |
| 83 | MP0003755_abnormal_palate_morphology | 0.54324402 |
| 84 | MP0002152_abnormal_brain_morphology | 0.54178321 |
| 85 | MP0004134_abnormal_chest_morphology | 0.53807925 |
| 86 | MP0000049_abnormal_middle_ear | 0.53369769 |
| 87 | MP0002064_seizures | 0.53103003 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.53045426 |
| 89 | MP0009046_muscle_twitch | 0.52218425 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 0.52100345 |
| 91 | MP0000955_abnormal_spinal_cord | 0.52014689 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.51043805 |
| 93 | MP0004742_abnormal_vestibular_system | 0.50533142 |
| 94 | MP0004130_abnormal_muscle_cell | 0.49490624 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.47259515 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.46484022 |
| 97 | MP0004147_increased_porphyrin_level | 0.45603129 |
| 98 | MP0003948_abnormal_gas_homeostasis | 0.44870620 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.44401263 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.44302047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 8.33931888 |
| 2 | Distal arthrogryposis (HP:0005684) | 6.47607225 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.39004123 |
| 4 | Round ear (HP:0100830) | 6.19339349 |
| 5 | Mask-like facies (HP:0000298) | 6.08794219 |
| 6 | Nemaline bodies (HP:0003798) | 5.69925494 |
| 7 | Abnormality of the sella turcica (HP:0002679) | 5.36598356 |
| 8 | Abnormality of the septum pellucidum (HP:0007375) | 5.31140119 |
| 9 | Absent phalangeal crease (HP:0006109) | 5.23509879 |
| 10 | Optic nerve hypoplasia (HP:0000609) | 5.21380359 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.09611032 |
| 12 | Absent septum pellucidum (HP:0001331) | 4.80915065 |
| 13 | Abnormal finger flexion creases (HP:0006143) | 4.64080104 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 4.61748326 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 4.60436782 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.51996318 |
| 17 | Hyperkalemia (HP:0002153) | 4.48547775 |
| 18 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 4.44960644 |
| 19 | Deformed tarsal bones (HP:0008119) | 4.24924001 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 3.98320787 |
| 21 | Periorbital edema (HP:0100539) | 3.53646452 |
| 22 | Facial edema (HP:0000282) | 3.39946577 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.32463651 |
| 24 | Growth hormone deficiency (HP:0000824) | 3.32112002 |
| 25 | Myopathic facies (HP:0002058) | 3.31322492 |
| 26 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 3.09341938 |
| 27 | Broad-based gait (HP:0002136) | 3.08930641 |
| 28 | Stomach cancer (HP:0012126) | 3.04708208 |
| 29 | Focal motor seizures (HP:0011153) | 2.80592699 |
| 30 | Conjunctival hamartoma (HP:0100780) | 2.79315157 |
| 31 | Hyperventilation (HP:0002883) | 2.75857838 |
| 32 | Metatarsus adductus (HP:0001840) | 2.71073737 |
| 33 | Asplenia (HP:0001746) | 2.65043384 |
| 34 | Overgrowth (HP:0001548) | 2.61252752 |
| 35 | Myoglobinuria (HP:0002913) | 2.57835111 |
| 36 | Abnormality of potassium homeostasis (HP:0011042) | 2.55781610 |
| 37 | Neoplasm of the heart (HP:0100544) | 2.45222257 |
| 38 | Increased connective tissue (HP:0009025) | 2.45059043 |
| 39 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.44229443 |
| 40 | Abnormal biliary tract physiology (HP:0012439) | 2.42347363 |
| 41 | Bile duct proliferation (HP:0001408) | 2.42347363 |
| 42 | Subacute progressive viral hepatitis (HP:0006572) | 2.40331516 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.39871411 |
| 44 | Primary amenorrhea (HP:0000786) | 2.33183011 |
| 45 | Epileptic encephalopathy (HP:0200134) | 2.33177238 |
| 46 | Myotonia (HP:0002486) | 2.30963923 |
| 47 | Megalencephaly (HP:0001355) | 2.28860712 |
| 48 | Abnormality of the calcaneus (HP:0008364) | 2.25355920 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.24479207 |
| 50 | Large earlobe (HP:0009748) | 2.21146055 |
| 51 | Difficulty running (HP:0009046) | 2.18951309 |
| 52 | True hermaphroditism (HP:0010459) | 2.16180390 |
| 53 | Protruding tongue (HP:0010808) | 2.10920815 |
| 54 | Furrowed tongue (HP:0000221) | 2.08994158 |
| 55 | Occipital encephalocele (HP:0002085) | 2.06346703 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.04133018 |
| 57 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.00319947 |
| 58 | Septo-optic dysplasia (HP:0100842) | 10.0672551 |
| 59 | Supernumerary spleens (HP:0009799) | 1.99386989 |
| 60 | Alveolar cell carcinoma (HP:0006519) | 1.96527843 |
| 61 | Hamartoma of the eye (HP:0010568) | 1.92692073 |
| 62 | Pancreatic cysts (HP:0001737) | 1.87119379 |
| 63 | Congenital sensorineural hearing impairment (HP:0008527) | 1.85486037 |
| 64 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.81500133 |
| 65 | Single umbilical artery (HP:0001195) | 1.81500133 |
| 66 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.81500133 |
| 67 | Down-sloping shoulders (HP:0200021) | 1.80555680 |
| 68 | Atrioventricular block (HP:0001678) | 1.80033362 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.78580566 |
| 70 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75202451 |
| 71 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.72623658 |
| 72 | Primary adrenal insufficiency (HP:0008207) | 1.71128564 |
| 73 | Wrist flexion contracture (HP:0001239) | 1.70514070 |
| 74 | Malignant hyperthermia (HP:0002047) | 1.69362007 |
| 75 | Hypoplastic ischia (HP:0003175) | 1.63520876 |
| 76 | Hypokalemia (HP:0002900) | 1.60255847 |
| 77 | Rhabdomyolysis (HP:0003201) | 1.60137418 |
| 78 | Chorioretinal atrophy (HP:0000533) | 1.60044825 |
| 79 | Fibular aplasia (HP:0002990) | 1.59924503 |
| 80 | 2-3 toe syndactyly (HP:0004691) | 1.58281368 |
| 81 | Natal tooth (HP:0000695) | 1.58045867 |
| 82 | Breech presentation (HP:0001623) | 1.57168476 |
| 83 | Cerebellar dysplasia (HP:0007033) | 1.56621315 |
| 84 | Heart block (HP:0012722) | 1.56608654 |
| 85 | Absent speech (HP:0001344) | 1.56107806 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 1.52802084 |
| 87 | Bone cyst (HP:0012062) | 1.52696072 |
| 88 | Smooth philtrum (HP:0000319) | 1.52417276 |
| 89 | Hyperuricemia (HP:0002149) | 1.52198357 |
| 90 | Increased purine levels (HP:0004368) | 1.52198357 |
| 91 | Hamartoma (HP:0010566) | 1.50924470 |
| 92 | Germ cell neoplasia (HP:0100728) | 1.50674421 |
| 93 | Intellectual disability, moderate (HP:0002342) | 1.50614369 |
| 94 | Bell-shaped thorax (HP:0001591) | 1.49968141 |
| 95 | Microglossia (HP:0000171) | 1.49016437 |
| 96 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.48702239 |
| 97 | Oligomenorrhea (HP:0000876) | 1.48154065 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 1.47042074 |
| 99 | Abnormality of chloride homeostasis (HP:0011422) | 1.46049612 |
| 100 | Embryonal renal neoplasm (HP:0011794) | 1.44152789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 9.77586863 |
| 2 | PBK | 3.57387522 |
| 3 | ERBB4 | 3.47130373 |
| 4 | PHKG2 | 3.46367557 |
| 5 | PHKG1 | 3.46367557 |
| 6 | OBSCN | 3.27064446 |
| 7 | TIE1 | 2.98694897 |
| 8 | MARK1 | 2.62298613 |
| 9 | WNK4 | 2.61079221 |
| 10 | CAMK1D | 2.54560475 |
| 11 | CAMK1G | 2.33576168 |
| 12 | TYRO3 | 1.98543558 |
| 13 | WNK1 | 1.95501193 |
| 14 | MAPK13 | 1.67958724 |
| 15 | MKNK2 | 1.66874473 |
| 16 | TNIK | 1.59282807 |
| 17 | STK39 | 1.50858377 |
| 18 | AKT3 | 1.50213756 |
| 19 | NUAK1 | 1.41622418 |
| 20 | PIK3CG | 1.34315154 |
| 21 | FRK | 1.33224998 |
| 22 | DMPK | 1.25767691 |
| 23 | CAMKK2 | 1.17903447 |
| 24 | PIK3CA | 1.14208512 |
| 25 | PINK1 | 1.13936963 |
| 26 | CAMK2G | 1.07645957 |
| 27 | STK16 | 1.01410193 |
| 28 | IRAK1 | 1.01118334 |
| 29 | PDK2 | 1.00414142 |
| 30 | JAK3 | 0.98468427 |
| 31 | CHEK2 | 0.90251318 |
| 32 | SGK2 | 0.88073880 |
| 33 | MAPK7 | 0.84803968 |
| 34 | DYRK2 | 0.84338358 |
| 35 | NME1 | 0.72594123 |
| 36 | DYRK1B | 0.71035390 |
| 37 | CSNK1A1L | 0.70624991 |
| 38 | MAP4K2 | 0.70602978 |
| 39 | CDK4 | 0.69349690 |
| 40 | NTRK3 | 0.68883791 |
| 41 | AKT2 | 0.65052007 |
| 42 | CSNK1G1 | 0.65013502 |
| 43 | MKNK1 | 0.64468026 |
| 44 | SGK1 | 0.62018390 |
| 45 | CAMK4 | 0.60801499 |
| 46 | LATS1 | 0.60291139 |
| 47 | PLK2 | 0.59768980 |
| 48 | SGK223 | 0.58180522 |
| 49 | SGK494 | 0.58180522 |
| 50 | MUSK | 0.57431370 |
| 51 | CCNB1 | 0.55821960 |
| 52 | CAMK1 | 0.55201198 |
| 53 | FER | 0.53018966 |
| 54 | MAP3K7 | 0.52405156 |
| 55 | CSNK1G2 | 0.51032379 |
| 56 | TAOK3 | 0.50914008 |
| 57 | DYRK3 | 0.49973306 |
| 58 | MAPK12 | 0.49543502 |
| 59 | ILK | 0.48310053 |
| 60 | DAPK2 | 0.48188521 |
| 61 | DDR2 | 0.45674514 |
| 62 | PRKG1 | 0.45438973 |
| 63 | CSNK1G3 | 0.44917290 |
| 64 | SRPK1 | 0.44680713 |
| 65 | SGK3 | 0.44203515 |
| 66 | YES1 | 0.44079635 |
| 67 | AURKA | 0.43029925 |
| 68 | MAP3K3 | 0.39756060 |
| 69 | MAP3K4 | 0.37266675 |
| 70 | ADRBK2 | 0.34416555 |
| 71 | CAMKK1 | 0.34299755 |
| 72 | STK38L | 0.34068717 |
| 73 | STK38 | 0.33120302 |
| 74 | PRKD2 | 0.30312386 |
| 75 | SCYL2 | 0.27225111 |
| 76 | PDGFRB | 0.26515022 |
| 77 | TEC | 0.26493180 |
| 78 | OXSR1 | 0.26228805 |
| 79 | GSK3A | 0.25871611 |
| 80 | CAMK2B | 0.25556366 |
| 81 | MAP2K7 | 0.24314918 |
| 82 | PRKCA | 0.23113651 |
| 83 | EPHA4 | 0.23035158 |
| 84 | PRKCE | 0.22966146 |
| 85 | ERBB2 | 0.21360457 |
| 86 | CAMK2D | 0.21359472 |
| 87 | PRKACA | 0.21089497 |
| 88 | PNCK | 0.20818299 |
| 89 | ATM | 0.19208111 |
| 90 | RPS6KA3 | 0.18000222 |
| 91 | PDGFRA | 0.17813429 |
| 92 | IGF1R | 0.16704565 |
| 93 | PKN1 | 0.16513728 |
| 94 | GSK3B | 0.16081129 |
| 95 | NEK6 | 0.15079472 |
| 96 | PRKACB | 0.14451520 |
| 97 | BRD4 | 0.14381031 |
| 98 | MAP3K12 | 0.13633048 |
| 99 | PRKD3 | 0.13335729 |
| 100 | RPS6KB1 | 0.12562245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tight junction_Homo sapiens_hsa04530 | 4.38118702 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.72258707 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.66007157 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.64575230 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56705840 |
| 6 | Long-term depression_Homo sapiens_hsa04730 | 2.45928137 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34747695 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.28041315 |
| 9 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.25992580 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.08486965 |
| 11 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.97112005 |
| 12 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.95442899 |
| 13 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.87449053 |
| 14 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.83614562 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78519103 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76525912 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.75803827 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.75019509 |
| 19 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.73901733 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61576212 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.58210243 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.53640200 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52601662 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48764192 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.36255430 |
| 26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.35421509 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35361339 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.33493720 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.29973838 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28959377 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.28701969 |
| 32 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.27081880 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24482177 |
| 34 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.23556732 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20964622 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13782830 |
| 37 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.13599066 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10326211 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09457085 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07063342 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.05913288 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01476402 |
| 43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.01379035 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96769715 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94499967 |
| 46 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94008521 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93882129 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.92540981 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90099213 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 0.89385022 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88119339 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.87332400 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83770810 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.83529016 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83074048 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83027922 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81561369 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.76897238 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74752405 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74351677 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.73905780 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.71385034 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69717285 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67877247 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.67134829 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63638384 |
| 67 | Melanoma_Homo sapiens_hsa05218 | 0.63179686 |
| 68 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62952780 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62377738 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62142738 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60738529 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.60502310 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59833557 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.58679387 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57783118 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57218674 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56504200 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56238128 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52195718 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51358137 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.50490252 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49018827 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48463340 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47333223 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44827436 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41735965 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41035512 |
| 88 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37991158 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37887112 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37817053 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37518999 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37433959 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37376370 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36283524 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35937514 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35752227 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35361121 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33413227 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33267566 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33180277 |

